Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patientsMasayoshi Yasui, Masaki Mori, Junichi Hasegawa et al.|The American Journal of Surgery|2015Cited by 19
Randomized phase II study of S-1 dosing schedule for resected colorectal cancerChu Matsuda, Masaki Mori, Mamoru Uemura et al.|BMC Cancer|2015Cited by 2
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal CancerJunichi Nishimura, Masaki Mori, Junichi Hasegawa et al.|Journal of the Anus Rectum and Colon|2020Cited by 2
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: A prospective, multicenter, open-label, single arm phase II study.Takeshi Kato, Hidetoshi Eguchi, Masataka Ikeda et al.|Journal of Clinical Oncology|2020Cited by 0